Skip to main content Skip to main navigation menu Skip to site footer

Clinical findings, laboratory, and imaging features of COVID-19 patients at Universitas Gadjah Mada (UGM) Academic Hospital, Yogyakarta, Indonesia

  • Ratna Dewi Puspita ,
  • Purwadi Sujalmo ,
  • Rizki Puji Agustin ,
  • Nesti Desi Ari ,


Background: The SARS-CoV-2 infection has triggered a global health crisis. Early detection of COVID-19 infection using hematology and radiology examination is the fastest method to detect the infection. This study aims to evaluate the characteristics of sign and symptom, hematology, and radiology examination of COVID-19 patients at Universitas Gadjah Mada (UGM) Academic Hospital, Yogyakarta, Indonesia.

Methods: This is a retrospective study with quantitative descriptive methods and uses a total sampling technique. This study was conducted at UGM Academic Hospital, with a total sample of 147 patients diagnosed with COVID-19. Data were collected from medical records and were analyzed with Microsoft Excel for Windows.

Results: This study showed that the most signs and symptoms of COVID-19 patients were cough (46.26%) and cold (37.41%), followed by hypertension (31.97%). Hematology examination showed that the leukocyte count of patients was mainly higher than the normal level (82.99%). The data showed that 22.45% of patients had increased C-Reactive Protein (CRP) and 2.72% of patients had increased procalcitonin. The result of thorax x-ray (16.33%) and CT-scan (28.57%) examination of the COVID-19 patients indicates pneumonia.

Conclusions: This study illustrated that the symptoms of COVID-19 patients at UGM Academic Hospital, Yogyakarta were various. Respiratory problems such as cough and cold were the most common symptoms, followed by muscle fatigue and digestive disorders. Hematology and radiology test results of COVID-19 patients depend on the severity of the disease. 



  1. Sharma A, Ahmad Farouk I, Lal SK. COVID-19: A Review on the Novel Coronavirus Disease Evolution, Transmission, Detection, Control and Prevention. Viruses. 2021;13(2):202.
  2. Guan WJ, Ni ZY, Hu Y, Liang W, Ou C, He J, et al. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020;382(18):1708-1720.
  3. He X, Lau EHY, Wu P, Deng X, Wang J, Hao X, et al. Temporal dynamics in viral shedding and transmissibility of COVID-19. Nat Med. 2020;26(5):672-675.
  4. Peng M. Outbreak of COVID-19: An emerging global pandemic threat. Biomed Pharmacother. 2020;129:110499.
  5. Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054-1062.
  6. Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA. 2020;323(11):1061-1069.
  7. Liu Y, Yang Y, Zhang C, Huang F, Wang F, Yuan J, et al. Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury. Sci China Life Sci. 2020;63(3):364-374.
  8. Yoon SH, Lee KH, Kim JY, Lee YK, Ko H, Kim KH, et al. Chest Radiographic and CT Findings of the 2019 Novel Coronavirus Disease (COVID-19): Analysis of Nine Patients Treated in Korea. Korean J Radiol. 2020;21(4):494-500.
  9. Brunese L, Mercaldo F, Reginelli A, Santone A. Explainable Deep Learning for Pulmonary Disease and Coronavirus COVID-19 Detection from X-rays. Comput Methods Programs Biomed. 2020;196:105608.
  10. Huang W, Berube J, McNamara M, Saksena S, Hartman M, Arshad T, et al. Lymphocyte Subset Counts in COVID-19 Patients: A Meta-Analysis. Cytometry A. 2020;97(8):772-776.
  11. Hu R, Han C, Pei S, Yin M, Chen X. Procalcitonin levels in COVID-19 patients. Int J Antimicrob Agents. 2020;56(2):106051.
  12. Huang S, Wang J, Liu F, Liu J, Cao G, Yang C, et al. COVID-19 patients with hypertension have more severe disease: a multicenter retrospective observational study. Hypertens Res. 2020;43(8):824-831. doi:10.1038/s41440-020-0485-2
  13. Wahab SF, Løgstrup BB. Atypical manifestations of COVID-19 in general practice: a case of gastrointestinal symptoms. BMJ Case Rep. 2020;13(8):e237520.
  14. Hu W, Lv X, Li C, Qi Y, Zhang Z, Li M, et al. Disorders of sodium balance and its clinical implications in COVID-19 patients: a multicenter retrospective study. Intern Emerg Med. 2021;16(4):853-862.
  15. Shi Q, Zhang X, Jiang F, Zhang X, Hu N, Bimu C, et al. Clinical Characteristics and Risk Factors for Mortality of COVID-19 Patients With Diabetes in Wuhan, China: A Two-Center, Retrospective Study. Diabetes Care. 2020;43(7):1382-1391.
  16. Velavan TP, Meyer CG. Mild versus severe COVID-19: Laboratory markers. Int J Infect Dis. 2020;95:304-307.
  17. Ruan Q, Yang K, Wang W, Jiang L, Song J. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med. 2020;46(5):846-848.
  18. Sahu BR, Kampa RK, Padhi A, Panda AK. C-reactive protein: A promising biomarker for poor prognosis in COVID-19 infection. Clin Chim Acta. 2020;509:91-94.
  19. Schuetz P. The Role of Procalcitonin for Risk Assessment and Treatment of COVID-19 Patients. Health Manage. 2020;20(5):380–382.
  20. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497-506.
  21. Zimmer MA, Zink AK, Weißer CW, Vogt U, Michelsen A, Priebe HJ, et al. Hypernatremia-A Manifestation of COVID-19: A Case Series. A A Pract. 2020;14(9):e01295.
  22. Pal R, Bhadada SK. COVID-19 and diabetes mellitus: An unholy interaction of two pandemics. Diabetes Metab Syndr. 2020;14(4):513-517.
  23. Krause M, Douin DJ, Tran TT, Fernandez-Bustamante A, Aftab M, Bartels K. Association between procalcitonin levels and duration of mechanical ventilation in COVID-19 patients. PLoS One. 2020;15(9):e0239174.
  24. Wong HYF, Lam HYS, Fong AHT, Leung ST, Chin TWY, Lo CSY, et al. Frequency and Distribution of Chest Radiographic Findings in Patients Positive for COVID-19. Radiology. 2020;296(2):E72-E78.
  25. Ng MY, Lee EYP, Yang J, Yang F, Li X, Wang H, et al. Imaging Profile of the COVID-19 Infection: Radiologic Findings and Literature Review. Radiol Cardiothorac Imaging. 2020;2(1):e200034.

How to Cite

Puspita, R. D., Sujalmo, P., Agustin, R. P., & Ari, N. D. (2021). Clinical findings, laboratory, and imaging features of COVID-19 patients at Universitas Gadjah Mada (UGM) Academic Hospital, Yogyakarta, Indonesia. Indonesia Journal of Biomedical Science, 15(2), 159–163.




Search Panel